Business context and reporting period
Genmab A/S filed this Form 6-K as a foreign private issuer for October 2026, dated October 7, 2026. The filing identifies a company announcement dated October 7, 2026 as Exhibit 99.1, but the announcement itself is not included in the supplied text.
Financial performance and position
The supplied filing text provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics.
Changes, outlook, risks, and unusual items
No operating changes, guidance, management commentary, risks, contingencies, or unusual items are described in the supplied text.
The 6-K states that it is incorporated by reference into Genmab’s listed Form S-8 registration statements, to the extent not superseded by later filings or reports.
Important facts to verify
- Obtain and review Exhibit 99.1, the company announcement dated October 7, 2026, for the substantive disclosure.
- Confirm whether the announcement contains financial or operational information not present in the supplied filing text.